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Asymmetric Growth and Development
of the Xenopus laevis Retina during Metamorphosis
Is Controlled by Type III Deiodinase
time as the shift to asymmetric growth, some of the
ganglion cell axons turn at the optic chiasm and inner-
vate the ipsilateral thalamus (Kennard, 1981; Hoskins
and Grobstein, 1984, 1985b). The cell bodies for the
ipsilaterally projecting ganglion cells reside mainly in the
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Baltimore, Maryland 21210 ventrotemporal retina periphery (Hoskins and Grobstein,
1985a). This region of the retina derives from the ventral
CMZ as a result of its exposure to TH. Thus, TH acts
on the CMZ not only to increase its proliferation, butSummary
also to affect the fate of cells that derive from it (Hoskins,
1986).During the metamorphosis of the Xenopus laevis ret-
Here we show that X-Notch-1-expressing cells of theina, thyroid hormone (TH) preferentially induces ven-
dorsal but not the ventral CMZ express type III deiodi-tral ciliary marginal zone (CMZ) cells to both increase
nase (D3), an enzyme that inactivates TH. TH inducestheir proliferation and give rise to ipsilaterally pro-
retina proliferation in a dose-dependent manner, withjecting ganglion cells. Here we show that dorsal CMZ
the dorsal CMZ cells being more resistant than the ven-cells express type III deiodinase (D3), an enzyme that
tral CMZ cells. This resistance is abrogated by iopanoicinactivates TH. The dorsal CMZ cells can be induced
acid, an inhibitor of deiodinases. D3 transgenes inhibitto proliferate if deiodinase activity is inhibited. D3 or
the response of the retina both to exogenous TH anddominant-negative thyroid hormone receptor trans-
during spontaneous metamorphosis. These findingsgenes inhibit both TH-induced proliferation of the ven-
demonstrate that the dorsal-specific expression of D3tral CMZ cells and the formation of the ipsilateral pro-
is critical for the development of asymmetric growth andjection. Thus, the localized expression of D3 in the
differentiation of the retina at metamorphosis.dorsal CMZ cells accounts for the asymmetric growth
of the frog retina.
Results
Introduction
D3 Is Expressed in Dorsal CMZ Cells
prior to MetamorphosisVarious aspects of the visual system of amphibians are
remodeled during metamorphosis (reviewed in Hoskins, In order to study the development of asymmetric growth
of the retina at metamorphosis, expression patterns of1990). Whereas in Xenopus laevis tadpoles, eyes are
positioned laterally and view completely different visual TH-inducible genes (Wang and Brown, 1993) were ana-
lyzed by in situ hybridization of sectioned retinas atfields, in frogs, eyes are positioned dorsorostrally and
have overlapping visual fields. Concomitant with this different stages during metamorphosis, stages 50±66.
Whereas many of these genes showed higher expres-shift in ocular positioning and function are changes in
the pattern of retinal proliferation and the formation of sion in ventral relative to dorsal retina at stage 63 (data
not shown), which is the climax of metamorphosis, onlya projection from the retina to the ipsilateral thalamus.
The premetamorphic tadpole retina grows by prolifer- D3 had an asymmetric expression in the retina around
stage 54, the time at which proliferation first becomesating symmetrically at the ciliary marginal zone (CMZ).
As the tadpole enters prometamorphosis after stage 54 asymmetric. In flatmount preparations at this stage, D3
mRNA expression is confined to the marginal cells in(Nieuwkoop and Faber, 1956), the CMZ increases in size
ventrally but not dorsally (Beach and Jacobson, 1979b), the dorsal third of the retina (Figure 1A). Expression
spreads ventrally as metamorphosis proceeds, fasterreaching a peak difference at the climax of metamorpho-
sis, but remaining asymmetrical into adulthood. Thus, down the nasal half of the retina (Figure 1B). D3 expres-
the majority of the adult frog retina is derived from ven- sion becomes uniform around the margin at metamor-
tral CMZ cells. The metamorphic shift from symmetrical phic climax and recedes from the retina after metamor-
to asymmetrical growth is TH dependent, since it is phosis (data not shown). Even though D3 was identified
inhibited by chemicals that inhibit the production of TH as a TH-inducible gene (Wang and Brown, 1991), its
(Hoskins and Grobstein, 1984, 1985c) and can be in- expression in the dorsal CMZ at the onset of metamor-
duced precociously by the addition of exogenous TH phosis appears to be independent of TH. D3 mRNA is
(Beach and Jacobson, 1979a). present in the dorsal CMZ at stage 36 (Figure 1C), and
Prior to metamorphosis, all axons coming from the thus, its appearance precedes the development of a
retina cross at the optic chiasm. The majority of these functional thyroid gland, which occurs at about stage
crossed axons innervate the optic tectum, while smaller 46 (D. D. B., unpublished results). A few cells expressing
numbers innervate the thalamus and the basal optic D3 mRNA can be found in the retina as early as stage
neuropil (Steedman et al., 1979). Beginning at the same 22 (data not shown).
As the expression domain of D3 mRNA spreads and
then recedes during the course of metamorphosis,* To whom correspondence should be addressed (e-mail: marsh-
armstrong@mail1.ciwemb.edu). whole retina D3 enzymatic activity also increases,
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Figure 1. D3 mRNA Is Expressed in the Ret-
ina prior to and during Metamorphosis
(A) D3 mRNA (blue) is expressed at stage 54 in
marginal cells in the dorsal third of the retina.
Flatmount view.
(B) By stage 59, D3 mRNA (blue) has spread
ventrally to over half of the margin, spreading
further down the nasal half of the retina. Flat-
mount view where nasal is to the right.
(C) At stage 36, D3 mRNA (blue) is already
expressed in the dorsal retina margin. Trans-
verse section.
(D) D3 enzymatic activity in the retina (open
circles) peaks at metamorphic climax. 1w
represents 1 week after metamorphosis. The
closed circle is the value obtained in the same
experiment for a tail of a stage 60 tadpole.
In (A)±(C), dorsal is up and black and white
arrowheads point to the dorsal and ventral
CMZ, respectively. Scalebars represent 100
mm in (A) and (B) and 50 mm in (C).
reaches a peak at metamorphic climax, and then de- increase in the number of progenitor cells, as there is
an increase in the number of cells expressing X-Notch-1creases (Figure 1D). The level of enzymatic activity at-
tained in the retina at metamorphic climax exceeds the mRNA in the ventral but not dorsal retina (Figures 3D
and 3C). The developmental profiles of proliferation inhighest level observed in the tail (Figure 1D; also see
St. Germain et al., 1994), the tissue from which this gene dorsal and ventral CMZ obtained by counting BrdU and
X-Notch-1 mRNA±positive cells (Figure 3E) agree wellwas originally cloned (Wang and Brown, 1991). How-
ever, only CMZ cells express D3 mRNA in the retina, with one another, and largely with the profile attained in
a previous study which used colcemid-induced mitoticeven at the peak of enzymatic activity. Thus, D3 mRNA±
expressing CMZ cells must have exceedingly high levels figures to assess proliferation (Beach and Jacobson,
1979b).of D3 enzymatic activity. This is supported by measure-
ments of D3 enzymatic activity in the retinas of stage
42 tadpoles and stage 36 embryos, in which the retinas
are smaller, and thus, the proportion of retina cells ex-
pressing D3 mRNA is larger (Table 1). Calculations
based on both the amount of enzymatic activity per
retina and the fraction of the retina that expresses D3
mRNA show that D3 mRNA±positive cells have constant
levels of enzymatic activity from embryogenesis up until
stage 54 (Table 1).
X-Notch-1 mRNA±Expressing Cells of the Ventral
Retina Lack D3 and Increase in Number
during Metamorphosis
At stage 54, when TH levels are just beginning to rise
(LeLoup and Buscaglia, 1977), proliferation in the retina
is still symmetrical around the CMZ (Beach and Jacob-
son, 1979b). This symmetry of proliferation is evident
by the equal incorporation of bromodeoxyuridine (BrdU)
into the dorsal and ventral CMZ (Figures 2A±2D). A sub-
set of CMZ cells, the nonstem cell progenitor cells, have
been shown to express X-Notch-1 mRNA (Perron et
al., 1998). X-Notch-1 mRNA is expressed equally in the
Figure 2. D3 mRNA Is Expressed in the X-Notch-1 mRNA±proliferating cells of the dorsal and ventral CMZ at stage
Expressing Cells of the Dorsal CMZ54 (Figures 2A and 2B). In contrast, D3 mRNA is present
(A) X-Notch-1 mRNA (blue) and BrdU (light brown) colocalize in cellsin the proliferating cells of the dorsal retina (Figure 2C)
of the dorsal CMZ at stage 54.
but not in those of the ventral retina (Figure 2D). In the (B) X-Notch-1 mRNA (blue) and BrdU (light brown) colocalize in cells
dorsal retina, D3 and X-Notch-1 mRNAs are coex- of the ventral CMZ at stage 54.
pressed in the same cells (Figure 2E). (C) D3 mRNA (blue) and BrdU (light brown) colocalize in cells of the
dorsal CMZ at stage 54.At stage 63, when TH levels are at their highest (Le-
(D) D3 mRNA (blue) is absent from BrdU (light brown)-positive cellsLoup and Buscaglia, 1977), proliferation in the ventral
in the ventral CMZ at stage 54.CMZ far exceeds that in the dorsal CMZ (Beach and
(E) D3 mRNA (blue) and X-Notch-1 mRNA (orange) colocalize inJacobson, 1979b). This asymmetry of proliferation is
dorsal, but not ventral CMZ, at stage 58.
evident by the difference in incorporation of BrdU into Black and white arrowheads point to the dorsal and ventral CMZ,
dorsal and ventral CMZ cells (Figures 3A and 3B). This respectively. Transverse sections. Scalebars represent 25 mm in
(A±D) and 50 mm in (E).increased ventral CMZ proliferation is due mainly to an
D3 in Metamorphic Retina Asymmetry
873
Figure 3. The Ventral Retina Increases Its
Proliferation during Spontaneous Metamor-
phosis
(A) Dorsal CMZ of stage 63 animal has few
BrdU-labeled cells.
(B) Ventral CMZ of stage 63 animal has many
BrdU-labeled cells.
(C) Dorsal CMZ of stage 63 animal has few
X-Notch-1 mRNA (blue)±positive cells.
(D) Ventral CMZ of stage 63 animal has many
X-Notch-1 mRNA (blue)±positive cells.
(E) The numbers of BrdU labeled cells (solid
lines) and X-Notch-1 mRNA±expressing cells
(dashed lines) increases in ventral CMZ (open
circles) but not dorsal CMZ (closed circles)
during spontaneous metamorphosis. Sample
sizes are n 5 4 for stages 52, 56, 58, and 1
week after metamorphosis (1w); n 5 5 for
stages 50, 54, and 66; n 5 6 for stage 60; and
n 5 8 for stage 62. Adjacent sections of the same retinas were used to obtain BrdU and X-Notch-1 counts.
In transverse sections (A±D), black and white arrowheads point to the dorsal and ventral CMZ, respectively, and scale bars represent 25 mm.
In (E), values are the mean 6 the standard error of the mean (SEM).
Dorsal CMZ Cells Are Resistant to Exogenous that of dominant-negative thyroid hormone receptor a
(DN) transgenes (Figure 5D).TH, but this Resistance Is Abrogated
by a Deiodinase Inhibitor
Beach and Jacobson (1979a) induced an asymmetric,
ventral but not dorsal, increase in proliferation in the Transgenic Expression of Physiological Levels
of D3 Inhibits Ventral CMZ Proliferationretinas of stage 50±54 tadpoles by the addition of exoge-
nous TH. Here we show that the ventral CMZ prolifera- at Metamorphic Climax
In order to test whether the level of D3 expression intion response to 3,39,5-triido-l-thyronine (T3) in stage
52±54 tadpoles is dose dependent (Figure 4A). The dor- the dorsal CMZ is sufficient to inhibit the proliferation
response during spontaneous metamorphosis, tadpolessal CMZ is capable of responding to T3 but requires a
higher concentration of the hormone. However, the dor- expressing D3 or DN transgenes under the control of
the NbT promoter were raised to metamorphosis. In thesal CMZ increases its proliferation in response to a low
concentration of T3 if the tadpoles are simultaneously retinas of stage 54 tadpoles carrying D3 transgenes,
D3 mRNA expression is typically seen in the CMZ, thetreated with iopanoic acid (IOPA), an inhibitor of deiodi-
nase activity (Galton, 1989) (Figure 4B). Similar dose ganglion cells, and the inner half of the inner nuclear
layer (Figure 6A). The levels of D3 mRNA expression inresponses for dorsal and ventral CMZ (Figure 4C) and
a similar response to IOPA (Figure 4D) are observed the ventral CMZ that are driven by the transgene are
below those seen (endogenous plus transgenic) in thewhen using stage 55±56 tadpoles and counting the num-
ber of X-Notch-1 mRNA±expressing cells. dorsal CMZ. Further confirmation that the transgenes
drive expression of D3 at levels below those seen in the
dorsal CMZ cells comes from measurements of the D3Transgenic Expression of D3 Inhibits TH-Induced
Retina Proliferation enzymatic activity of pooled control and transgenic reti-
nas (Table 1). The D3 enzymatic activity calculated toSince many metamorphic-like changes can be elicited
in young tadpoles by treatment with exogenous T3, we exist in the D3-positive cells of the dorsal CMZ is higher
than that driven by the transgenes.have used this assay to study the effect of transgenes
on metamorphic programs (Huang et al., 1999). Young Measuring proliferation by cell counts of either BrdU±
(Figure 6B) or X-Notch-1 mRNA (Figure 6C)±positivetadpoles treated with T3 undergo proliferation increases
in skin, limb bud, some cartilage, olfactory epithelia, cells shows that D3 transgenes are as effective as DN
transgenes at inhibiting the climax levels of proliferationbrain, and spinal cord (data not shown). Retina prolifera-
tion is also increased in young tadpoles by exogenous in the ventral CMZ. The low amount of proliferation in
the dorsal CMZ cells appears to be thyroid hormoneT3 (Figures 5A and 5B) in a dose-dependent manner
(Figure 5C). independent, since it is unaffected by D3 and DN
transgenes. These results demonstrate that the levelsYoung tadpoles expressing D3 transgenes under the
control of a panactive strong promoter, CMV, have al- of D3 that are present in the dorsal CMZ are sufficient
to inhibit the TH-induced proliferation increase that oc-ready been shown to be resistant to morphological
changes elicited by exogenous T3 (Huang et al., 1999). curs in the ventral CMZ during metamorphosis.
Here we show that expression of D3 with the CMV pro-
moter protects the retina from the proliferation-inducing
activity of exogenous T3 (Figure 5D). Expression of D3 D3 Transgenes also Inhibit the Formation
of the Ipsilateral Retinothalamic Projectionwith a neural-specific promoter, from the neural b-tubu-
lin (NbT) gene, similarly protects the retina (Figure 5D) Another means of quantitating the effect of TH on the
CMZ is to count the number of ipsilaterally projectingwithout affecting changes elicited by exogenous T3 on
nonneural tissues (data not shown). With both promot- ganglion cells, since the ipsilateral retinothalamic pro-
jection develops from the CMZ at metamorphosis asers, the protective action of D3 transgenes is similar to
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Figure 4. Ventral CMZ Cells Proliferate in Response to Low Concen-
trations of T3, but Dorsal CMZ Cells Are also Capable of Responding
(A) Treatment of stage 52±54 tadpoles with low concentrations of
T3 for 4 days increases the number of BrdU-labeled cells in the
ventral CMZ (open circles), while higher concentrations are required
to increase the number of BrdU-labeled cells in the dorsal CMZ
(closed circles). Sample sizes are n 5 7 for 0 nM, 1 nM, and 10 nM;
n 5 8 for 3 nM; and n 5 5 for 30 nM.
(B) Treatment of stage 52±54 tadpoles with 5 mM iopanoic acid
(IOPA) allows a low concentration of T3, 3 nM, to increase the num-
ber of BrdU-labeled cells in the dorsal CMZ (black bars) to levels
comparable to those induced by T3 in the ventral CMZ (white bars).
Values from retinas not treated with IOPA are the same as those
graphed in (A). Values from retinas treated with IOPA are from the
same experiment and have sample sizes of n 5 8 for the group not
treated with T3, and n 5 7 for the group treated with T3. The dorsal
retina value in the presence of both IOPA and T3, marked with *, is
significantly different (p , 0.0001) relative to other dorsal values by
ANOVA Bonferroni/Dunn posthoc test.
(C) Treatment of stage 55±56 tadpoles with low concentrations of
T3 for 5 days increases the number of X-Notch-1 mRNA±expressing
cells in the ventral CMZ (open circles), while higher concentrations
are required to increase the number of X-Notch-1 mRNA±expressing
cells in the dorsal CMZ (closed circles). Sample sizes are n 5 3
for 0 nM, n 5 4 for 1 nM, n 5 5 for 3 nM and 30 nM, and n 5 6 for
Figure 5. D3 Transgenes Inhibit T3-Induced Retina Proliferation in10 nM.
Young Tadpoles(D) Treatment of stage 55±56 tadpoles with 5 mM iopanoic acid
(IOPA) allows 3 nM T3 to increase the number of BrdU-labeled cells (A) Some proliferation is seen in the retina of a 2-week-old tadpole
in the dorsal CMZ (black bars) to levels comparable to those induced in the absence of T3. Lateral view.
by T3 in the ventral CMZ (white bars). Values from retinas not treated (B) More proliferation is seen in the retina of a 2-week-old tadpole
with IOPA are the same as those graphed in (C). Values from retinas kept for the second week in 10 nM T3. Lateral view.
treated with IOPA are from the same experiment and have sample (C) T3 increases retina proliferation in young tadpoles in a dose-
sizes of n 5 2 for the group not treated with T3, and n 5 3 for the dependent manner. Sample sizes are n 5 9 for all except 3 nM,
group treated with T3. The dorsal retina value in the presence of which is n 5 10, and 10 nM, which is n 5 8.
both IOPA and T3, marked with *, is significantly different (p 5 (D) D3 transgenes and dominant-negative thyroid hormone receptor
0.0002) relative to dorsal retina value in the presence of IOPA alone, a (DN) transgenes inhibit the retina proliferation that is induced by
and the other two dorsal retina values (p , 0.0001) by ANOVA 10 nM T3. CN represents the control group, which are transgenic
Bonferroni/Dunn posthoc test. animals expressing GFP. Sample sizes are n 5 5 for CN, n 5 11 for
Values are mean 6 SEM. CMV:DN, n 5 16 for CMV:D3, n 5 22 for NbT:DN, and n 5 8 for
NbT:D3. CN, marked with *, differs (p , 0.0001) from all other groups,
while CMV:DN, marked with **, differs from CMV:D3 (p 5 0.0058)
and all other groups (p , 0.0001) by ANOVA Bonferroni/Dunn post-a result of its exposure to TH (Hoskins, 1986). This pro-
hoc test.jection was quantitated by a novel, vital method: unilat-
In (A)±(B), scalebars represent 100 mm, and retina axes are unknown.
eral thalamic injection of 49,6-diamidino-2-phenylindole In (C)±(D), values are mean 6 SEM.
(DAPI), followed 2 days later by the counting of labeled
nuclei in live retinas. In such specimens, fluorescent
D3 in Metamorphic Retina Asymmetry
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Figure 6. D3 Transgenes Inhibit the Ventral
CMZ Proliferation Response at Metamorphic
Climax
(A) D3 transgene expression driven by the
NbT promoter, detected with a D3 antisense
probe, is seen in the ventral CMZ in this trans-
verse section of the retina of a stage 54 tad-
pole. D3 transgene expression in the ventral
CMZ (white arrowhead) is lower than the
combined endogenous and transgenic D3 ex-
pression in the dorsal CMZ (black ar-
rowhead).
(B) D3 and DN transgenes driven by the NbT
promoter reduce the number of BrdU-labeled
cells in the ventral, but not the dorsal, CMZ
at stage 63. Black and white bars show
results with dorsal and ventral CMZ, respectively. CN represents the control group, which are animals made by nuclear transplantation but
which do not carry any transgenes. Sample sizes are n 5 12 for CN, n 5 7 for DN, and n 5 11 for D3.
(C) D3 and DN transgenes driven by the NbT promoter reduce the number of X-Notch-1 mRNA±expressing cells in the ventral, but not dorsal,
CMZ at stage 63. Black and white bars show results with dorsal and ventral CMZ, respectively. Sample sizes are as shown in (B).
In (A) (transverse section), dorsal is up, and scalebar represents 100 mm. In (B)±(C), values are mean 6 SEM, and bars with * are significantly
different (p , 0.0001) relative to control by ANOVA Bonferroni/Dunn posthoc test.
label is present throughout the retina that is contralateral does not respond to TH like the ventral retina because
progenitor cells in the dorsal retina express D3, an en-to the injection (Figure 7A), but is confined to the ventro-
temporal periphery of the retina that is ipsilateral to the zyme that inactivates TH.
injection (Figure 7B). This pattern matches that de-
scribed for the ipsilateral retinothalamic projection
TH Promotes Retina Proliferation
(Hoskins and Grobstein, 1985a). A closer view of DAPI-
Previous studies have shown that exogenous TH can
labeled cells in the ipsilateral retina shows mainly nuclear
increase ventral retina proliferation (Beach and Jacob-
labeling (Figure 7C). This retrograde labeling method
son, 1979b), and that inhibition of endogenous TH syn-
allows us to quantitate the number of the ipsilaterally
thesis prevents the metamorphic increase in ventral ret-
projecting ganglion cells present during and after meta-
ina proliferation and the formation of the ipsilateral
morphosis (Figure 7D). Animals expressing either D3 or
retinothalamic projection (Hoskins and Grobstein, 1984,
DN transgenes have reduced numbers of ipsilaterally
1985c). We show here that retina proliferation can be
projecting ganglion cells at the climax of metamorphosis
induced by exogenous TH in a dose-dependent manner
(Figure 7E), further demonstrating that D3 expression
(Figures 4A, 4C, and 5C). Only ventral CMZ cells respond
inhibits the TH-induced metamorphic response of the
at low levels of TH, but dorsal CMZ cells can be induced
ventral CMZ.
to proliferate by higher levels of TH (Figures 4A and 4C).
However, the dorsal CMZ cells will respond to lower
Discussion
levels of TH if deiodinase activity is pharmacologically
inhibited (Figures 4B and 4D).
It has been known for two decades (Beach and Jacob-
son, 1979b) that, during metamorphosis, proliferation in
the ventral but not the dorsal retina matches the levels D3 Expression Negatively Correlates
with Metamorphic Proliferationof circulating TH (LeLoup and Buscaglia, 1977). Using
two different assays, BrdU incorporation and X-Notch-1 Even though D3 is confined to the dorsal retina starting
in embryogenesis (Figure 1C), it is unlikely to be per-mRNA expression (Figure 3E), we confirm these results.
The reason why the response of the dorsal retina differs forming any function there until much later, during
prometamorphosis, when the levels of TH begin to rise.from that of the ventral retina at metamorphosis has
remained a mystery. Here we show that the dorsal retina At this latter time, TH begins to cause profound changes
Table 1. Deiodinase Activity in Premetamorphic Retinas
% of Retina D3 Activity D3 Activity/Cell
Stagea Expressing D3 mRNAb (fmol/min • mg retina)c (relative units)d
36 7.2 65 0.8
42 3.8 36 0.8
54 0.6 7 1
54 (TR) 43.9 144 0.3
a Stages of normal animals; 54(TR), retinas from stage 54 tadpoles expressing NbT:D3 transgenes.
b Determined in sections by area measurements of D3 mRNA expression domain over total retina area.
c Enzymatic activity determined as described (Huang et al., 1999).
d Estimate of the relative average D3 enzymatic activity per D3 mRNA±positive cell, determined by dividing the value in the second column
by the value in the third column and then normalizing to the stage 54 value taken as 1.
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Figure 7. D3 transgenes Inhibit the Ipsilateral
Retinothalamic Projection
(A) DAPI injection into the left thalamus labels
cells throughout the right retina of this stage
66 animal.
(B) DAPI injection into the left thalamus labels
cells only in the ventrotemporal periphery of
the left retina of this 1 week±postmetamor-
phic animal.
(C) DAPI localizes to the nuclei of ipsilaterally
projecting ganglion cells.
(D) The number of ipsilaterally projecting gan-
glion cells increases during and after meta-
morphosis. Sample sizes are n 5 2 for stages
54 and 56, n 5 6 for stage 58, n 5 7 for stage
62, n 5 4 for stage 66, n 5 11 for 1 week
postmetamorphosis (1w), and n 5 4 for 2
weeks postmetamorphosis (2w).
(E) D3 and DN transgenes inhibit the number
of ipsilaterally projecting ganglion cells mea-
sured at stage 63. CN represents the control
group, which are animals made by nuclear
transplantation but which do not carry any
transgenes. Sample sizes are n 5 18 for CN,
n 5 8 for DN, and n 5 12 for D3.
In (A) and (B), dorsal is up, nasal is right, and
scale bars represent 500 mm. In (C), scalebar
represent 10 mm. In (D) and (E), values are
mean 6 SEM, and bars with * are significantly
different (p , 0.0001) relative to control by
ANOVA Bonferroni/Dunn posthoc test.
throughout the tadpole, and only then should the ex- reduced amount of proliferation in their ventral retinas
(Figure 6B±6C) and a reduced number of ipsilaterallypression of D3 influence cell behavior. Indeed, it is at
this time that the ventral CMZ cells, which lack D3, projecting ganglion cells (Figure 7E). The inhibition of
the metamorphic response in the ventral CMZ cells isincrease their proliferation, while the dorsal CMZ cells,
which have high levels of D3, fail to increase their prolif- substantial even though the levels of D3 attained in these
transgenic animals are below the levels present in theeration.
The pattern of proliferation observed in the retina at dorsal CMZ cells (Figure 6A and Table 1). In addition,
the observation that in both induced (Figure 5D) andthe climax of metamorphosis mirrors the pattern of D3
mRNA observed during the course of metamorphosis. spontaneous (Figures 6B±6C and 7E) metamorphic
assays, D3 transgenes are as effective as dominant-The dorsal-most CMZ cells acquire D3 expression first
and retain this expression throughout prometamorpho- negative thyroid hormone receptor transgenes demon-
strates that D3 is a potent TH-inhibiting mechanism.sis. Consequently, dorsal-most CMZ cells show the least
amount of proliferation. The ventral-most CMZ cells ac-
quire D3 expression last, just as the TH levels are them-
selves about to decline. Consequently, ventral-most How Does D3 Regulate the Pattern of Growth
of the Retina?CMZ cells show the largest amount of proliferation. The
middle CMZ cells acquire D3 expression during the We have demonstrated that the localized expression of
D3 is sufficient to explain the shift from symmetric tocourse of prometamorphosis, and do so in a dorsal to
ventral fashion. Consequently, middle CMZ cells show asymmetric growth that occurs in the retina at metamor-
phosis. By localizing the expression of the enzyme thatan intermediate, ventral to dorsal graded, amount of
proliferation. Even a subtle temporonasal difference in destroys TH, different regions of the retina can respond
differentially to the same levels of circulating TH. Thisproliferation (Tay et al., 1982) is mirrored by the expres-
sion pattern of D3 as it spreads around the CMZ during generation of a graded response to a systemic signal
constitutes a novel mechanism. A similar mechanismprometamorphosis (Figure 1B). Thus, the expression of
D3 fully correlates negatively with metamorphic prolifer- could underlie the development of other biological gra-
dients.ation in the retina.
Xenopus laevis retina progenitor cells, partly by modu-
lation of the Notch pathway (Dorsky et al., 1995, 1997),Transgenic Expression of D3 Inhibits the Metamorphic
Response of the Retina respond to both intrinsic and extrinsic cues, and make
decisions regarding their proliferation and differentia-Transgenic expression of D3 inhibits the increase in
retina proliferation that is induced by exogenous TH tion. We show here that these same progenitor cells are
critical for mediating the metamorphic action of TH inin young tadpoles (Figure 5D). Transgenic animals that
express D3 throughout their CMZ have a stunted ventral the retina. If they fail to receive TH, as they do in the
dorsal CMZ because of the presence of D3, metamor-retina growth response during spontaneous metamor-
phosis. At metamorphic climax, these animals show a phic changes, such as the increase in progenitor cell
D3 in Metamorphic Retina Asymmetry
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peripheral halves of retinas from albino tadpoles were placed ontoproliferation and the formation of ipsilaterally projecting
SectionLock slides (Polysciences, Inc., Warrington, PA), coveredganglion cells, will not occur.
with Tissue-Tek OCT compound (EM Sciences, Ft. Washington, PA),Eye inversion studies in embryos have shown that
flattened with forceps, each covered with a plastic coverslip, and
the growth pattern of the retina at metamorphosis is frozen on a metal block over dry-ice. The X-Notch-1 probe has been
determined during embryogenesis (Beach and Jacob- described (Perron et al., 1998). Simultaneous detection of two gene
products by in situ hybridization was accomplished by hybridizingson, 1979c). We show here that D3 is expressed in the
simultaneously with two probes: a fluorescein-labeled (Boehringer-dorsal retina starting at embryogenesis. This expression
Mannheim, Indianapolis, IN) X-Notch-1 probe, and a digoxigenin-is indeed critical for determining the pattern of growth
labeled D3 probe. D3 signal was detected first with NBT/BCIP, andthat occurs at metamorphosis. After metamorphosis,
after inactivating the antibody with a 30 min incubation in 1 M gly-
both TH and D3 decline, and the continued growth of cine, pH 2.2, the X-Notch-1 signal was detected with INT (Molecular
the retina becomes independent of TH (Beach and Ja- Probes, Eugene, OR)/BCIP. In the X-Notch-1 mRNA cell counting
experiments, sections adjacent to those used to obtain the BrdUcobson, 1979b). Yet both the asymmetric pattern of pro-
counts were used, and an average of four sections were counted perliferation and the generation of ipsilaterally projecting
retina. D3 enzymatic activity was measured as previously describedganglion cells continue into adulthood. Therefore, the
(Huang et al., 1999) using pools of 200 eyes for stages 36 and 42,D3 expression pattern is established during embryogen-
and pools of 20 retinas for stages 54 and higher.
esis, the D3 enzyme functions during metamorphosis,
and the effects of D3 expression on the development
Retrograde Labeling of the Ipisilateral
and function of the retina endure throughout the life of Retinothalamic Projection
the postmetamorphic frog. A procedure for labeling the retinothalamic ipsilateral projection
(SchuÈ tte and Hoskins, 1993) was modified in order to facilitate quan-
titation. A small hole was burned through the skin and skull of anes-Experimental Procedures
thetized tadpoles. Using a Nanoject Variable Automatic Injector
(Drummond Scienctific Co., Broomal, PA), 3 to 5 separate injectionsAnimals, T3 Treatments, and Transgenesis
of 4.8 nl of retrograde label, which included 1 part of 10 mg/mlAnimals were raised under standardized conditions (Huang et al.,
lysolecithin and 3 parts of 2.5% 49,6-diamidino-2-phenylindole1999) and staged (Nieuwkoop and Faber, 1956). T3 inductions of
(DAPI; Sigma, St. Louis, MO), were made into the left thalamusyoung tadpoles were performed for 7 days as described (Huang et
of each animal. Two days after being injected, the animals wereal., 1999). T3 inductions of stage 52±54 tadpoles for BrdU counts
anesthetized, and their retinas were dissected out. Each retina wasand of stage 55±56 tadpoles for X-Notch-1 mRNA counts were car-
cut along four or more places to allow flattening, transferred toried out for 4 and 5 days, respectively, in the presence or absence
a slide, covered with Tissue-Tek OCT compound, flattened withof 5 mM iopanoic acid (Sigma, St. Louis, MO). Constructs were made
forceps, and covered with a coverslip over a one coverslip bridge.in pCS21-based vectors and used either the cytomegalovirus (CMV)
Immediately, the retinas were viewed with a fluorescence micro-promoter/enhancer (Turner and Weintraub, 1994), or 3.8 kb of regu-
scope, using a MTI CCD-72 camera (Dage MTI, Michigan City, IN)latory regions from the Xenopus laevis NbT gene. Constructs were
to project the image onto a video monitor with a 6 3 8 grid. DAPI-made with both promoters driving either a GFP-fused version of D3
labeled nuclei were counted at 2303 magnification. Most of the(Huang et al., 1999) or a GFP-fused version of a dominant-negative
transgenic animals were used to obtain both ipsilateral retinotha-thyroid hormone receptor a (DN). The DN cDNA was made by cloning
lamic projection counts and BrdU/X-Notch-1 counts.PCR-amplified amino acids 2±401 of TRa into pCS21GFP* (Huang
et al., 1999). Transgenic animals were prepared by REMI/nuclear
transplantation (Kroll and Amaya, 1996) using minor modifications Acknowledgments
(Huang et al., 1999). Animals expressing the transgenes were identi-
fied by their GFP fluorescence at 2 to 7 days of development using We thank Dave Turner for the pCS21 vectors, Enrique Amaya for
a Leica fluorescence dissecting microscope and were confirmed by the NbT21 vector, and William Harris for the X-Notch-1 probe. This
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BrdU Labeling, In Situ Hybridization, and D3 Enzymatic Assay grant from the G. Harold and Leila Y. Mathers Charitable Trust to
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with 1.25 ml of 20 mM BrdU and were processed for immunohisto- requirements for the Ph.D. degree at Johns Hopkins University.
chemistry 15 hr later (Berry et al., 1998). In order to count the number
of BrdU and X-Notch-1 mRNA±positive cells, 18 sections 50 mm
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apart were taken for each retina, and multiple sections in the central
part of each retina were counted at 5003 magnification. In the BrdU
Referencescounting experiments, a fluorescent secondary antibody (TRITC
anti-mouse IgG, Cappel, Durham, NC) was used, and an average of
Beach, D.H., and Jacobson, M. (1979a). Influences of thyroxine onsix sections were counted per retina. Young tadpoles treated with
cell proliferation in the retina of the clawed frog at different ages.T3 received an intraperitoneal injection of 0.25 ml of 20 mM BrdU
J. Comp. Neurol. 183, 615±623.(Sigma, St. Louis, MO) on day 7 of treatment and, 12 hr later, were
fixed in 2% trichloroacetic acid for 2 hr at room temperature. The Beach, D.H., and Jacobson, M. (1979b). Patterns of cell proliferation
specimens were bleached at room temperature in 19.8% hydrogen in the retina of the clawed frog during development. J. Comp. Neurol.
peroxide, 6.66% DMSO, 26.64% methanol for about a week, until 183, 603±613.
the specimens lost eye pigmentation. After immunohistochemical Beach, D.H., and Jacobson, M. (1979c). Patterns of cell proliferation
detection (Berry et al., 1998), the eyes were dissected out using 000 in the developing retina of the clawed frog in relation to blood supply
insect pins (Fine Science Tools, Inc., Foster City, CA), transferred and position of the choroidal fissure. J. Comp. Neurol. 183, 625±632.
onto microscope slides, and each covered with a coverslip over a
Berry, D.L., Rose, C.S., Remo, B.F., and Brown, D.D. (1998). Theone coverslip bridge. BrdU-labeled nuclei were counted using a
expression pattern of thyroid hormone response genes in remodel-fluorescence microscope at 5003 magnification. Fluorescence im-
ing tadpole tissues defines distinct growth and resorption geneages were captured using an RTE-CCD-1317-K11 digital camera
expression programs. Dev. Biol. 203, 24±35.(Princeton Instruments, Trenton, NJ) and IPlab Spectrum (Signal
Dorsky, R.I., Rapaport, D.H., and Harris, W.A. (1995). Xotch inhibitsAnalytics Corporation, Vienna, VA) software.
cell differentiation in the Xenopus retina. Neuron 14, 487±496.In situ hybridization experiments were performed as previously
described (Berry et al., 1998). For the flatmount preparations, the Dorsky, R.I., Chang, W.S., Rapaport, D.H., and Harris, W.A. (1997).
Neuron
878
Regulation of neuronal diversity in the Xenopus retina by Delta sig-
naling. Nature 385, 67±70.
Galton, V. (1989). The role of 3,5,39-triiodothyronine in the physiologi-
cal action of thyroxine in the premetamorphic tadpole. Endocrinol-
ogy 124, 2427±2433. Erratum: Endocrinology 127 (4), 1977.
Hoskins, S.G. (1986). Control of the development of the ipsilateral
retinothalamic projection in Xenopus laevis by thyroxine: results and
speculation. J. Neurobiol. 17, 203±229.
Hoskins, S.G. (1990). Metamorphosis of the amphibian eye. Review.
J. Neurobiol. 21, 970±989.
Hoskins, S.G., and Grobstein, P. (1984). Induction of the ipsilateral
retinothalamic projection in Xenopus laevis by thyroxine. Nature
307, 730±733.
Hoskins, S.G., and Grobstein, P. (1985a). Development of the ipsilat-
eral retinothalamic projection in the frog Xenopus laevis. I. Retinal
distribution of ipsilaterally projecting cells in normal and experimen-
tally manipulated frogs. J. Neurosci. 5, 911±919.
Hoskins, S.G., and Grobstein, P. (1985b). Development of the ipsilat-
eral retinothalamic projection in the frog Xenopus laevis. II. Ingrowth
of optic nerve fibers and production of ipsilaterally projecting retinal
ganglion cells. J. Neurosci. 5, 920±929.
Hoskins, S.G., and Grobstein, P. (1985c). Development of the ipsilat-
eral retinothalamic projection in the frog Xenopus laevis. III. The role
of thyroxine. J. Neurosci. 5, 930±940.
Huang, H., Marsh-Armstrong, N., and Brown, D.D. (1999). Metamor-
phosis is inhibited in transgenic Xenopus laevis tadpoles that over-
express type III deiodinase. Proc. Natl. Acad. Sci. USA 96, 962±967.
Kennard, C. (1981). Factors involved in the development of ipsilateral
retinothalamic projections in Xenopus laevis. J. Embryol. Exp. Mor-
phol. 65, 199±217.
Kroll, K.L., and Amaya, E. (1996). Transgenic Xenopus embryos from
sperm nuclear transplantations reveal FGF signaling requirements
during gastrulation. Development 122, 3173±3183.
LeLoup, J., and Buscaglia, M. (1977). La triiodothyronine, hormone
de la metamorphose des amphibiens. C. R. Acad. Sci. 284, 2261±
2263.
Nieuwkoop, P.D., and Faber, J. (1956). Normal Table of Xenopus
laevis (Daudin): A Systematical and Chronological Survey of the
Development from the Fertilized Egg Till the End of Metamorphosis
(New York: Elsevier/North-Holland).
Perron, M., Kanekar, S., Vetter, M.L., and Harris, W.A. (1998). The
genetic sequence of retinal development in the ciliary margin of the
Xenopus eye. Devel. Biol. 199, 185±200.
SchuÈ tte, M., and Hoskins, S.G. (1993). Ipsilaterally projecting retinal
ganglion cells in Xenopus laevis: an HRP study. J. Comp. Neurol.
331, 482±494.
St. Germain, D., Schwartzman, R.A., Croteau, W., Kanamori, A.,
Wang, Z., Brown, D.D., and Galton, V.A. (1994). A thyroid hormone±
regulated gene in Xenopus laevis encodes a type III iodothyronine
5-deiodinase. Proc. Natl. Acad. Sci. USA 91, 7767±7771. Erratum:
Proc. Natl. Acad. Sci. USA 91 (23), 11282.
Steedman, J.G., Stirling, R.V., and Gaze, R.M. (1979). The central
pathways of optic fibres in Xenopus tadpoles. J. Embryol. Exp.
Morphol. 50, 199±215.
Tay, D., Hiscock, J., and Straznicky, C. (1982). Temporo-nasal asym-
metry in the accretion of retinal ganglion cells in late larval and
postmetamorphic Xenopus. Anat. Embryol. 164, 75±83.
Turner, D.L., and Weintraub, H. (1994). Expression of achaete-scute
homolog 3 in Xenopus embryos converts ectodermal cells to a neu-
ral fate. Genes Dev. 8, 1434±1447.
Wang, Z., and Brown, D.D. (1991). A gene expression screen. Proc.
Natl. Acad. Sci. USA 88, 11505±11509.
Wang, Z., and Brown, D.D. (1993). Thyroid hormone±induced gene
expression program for amphibian tail resorption. J. Biol. Chem.
268, 16270±16278.
